The downgrade is based on several factors, including CHI’s continued weak operating performance and decline of unrestricted cash and investments.
The outlook is negative, reflecting CHI’s sizable decline in operating performance since 2012.
Moody’s also downgraded CHI’s variable rate demand bonds to “A3/VMIG 2” from “A2/VMIG 1” and its commercial paper to “P-2” from “P-1.”
More articles on healthcare finance:
Opponents come out against proposal to charge Ohio Medicaid enrollees
Fitch assigns ‘A’ rating to Inspira Health’s bonds
Independent emergency group taps McKesson for RCM services
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.